Search results
Age-Related Macular Degeneration: Putting a Hole in Our World
WebMD· 13 hours agoWhen we’re young, we take our macula for granted. At the center of our retina – the deepest layer of the eye that’s chock-full of photoreceptors and that confers color to our world – the macula ...
Earnings call: Lineage Cell Therapeutics reports positive OpRegen trial results By Investing.com
Investing.com· 9 hours agoThe therapy showed an average gain in visual acuity, contrasting with the typical loss experienced...
Lineage Cell Therapeutics Q1 2024 Earnings: Aligns with EPS Projections Amidst Revenue Declines
GuruFocus.com via Yahoo Finance· 9 hours agoPartnership Developments: Established a new services agreement with Genentech to advance the OpRegen program, enhancing...Their diverse pipeline includes therapies like OpRegen ...
Telomir Pharmaceuticals sees breakthrough potential in Anti-Aging Treatment with Telomir 1
Proactive Investors· 4 days agoDuring a recent interview, O'Donnell...ophthalmology at Johns Hopkins, O'Donnell explained that the...
Research to Prevent Blindness Opens Applications for Vision Research Grants
Newswise· 6 days agoWith a focus on scientific excellence, RPB funds research across all sight-threatening conditions, including glaucoma, age-related macular degeneration, ...
Adverum Biotechnologies Reports Q1 2024 Results: A Detailed Look at Financials and Pipeline Progress
GuruFocus.com via Yahoo Finance· 9 hours agoWith a stronger financial position and exciting data from ongoing clinical trials, Adverum is well-positioned to continue its mission of setting new standards in the
These 2 ‘Strong Buy’ Penny Stocks Could Surge Over 400%, Says Oppenheimer
TipRanks via Yahoo Finance· 1 day agoRisk and reward are the yin and yang of stock trading, the two essential yet opposing forces in...
Bright Sight Eye Care to offer optical services, products in Georgetown
Community Impact· 1 day agoThe new clinic will provide glasses, contacts and eye disease treatment.
STEALTH BIOTHERAPEUTICS' BARTH SYNDROME NDA RECEIVES PRIORITY REVIEW DESIGNATION
FOX 59 Indianapolis· 4 days agoFood and Drug Administration ("FDA") has now determined that its New Drug Application ("NDA") for elamipretide for the treatment of Barth syndrome is entitled ...
Study: For treating retinopathy of prematurity, UB-led research proves that ranibizumab is safe
UB Reporter· 9 hours agoROP occurs in low birthweight premature babies; if not treated, it can lead to blindness. The study, published in eClinicalMedicine online before print on April 11, answers a longstanding concern ...